000 03409nam a22003615i 4500
999 _c80178
_d80178
_x1
001 80178
003 ES-MaUEC
005 20230202102447.0
007 cr nn 008mamaa
008 131204s2014 xxu| s |||| 0|eng d
020 _a9781461483380
024 7 _a10.1007/978-1-4614-8338-0
_2doi
040 _dES-MaUEC
050 4 _aRE661.D3
_bP384 2014
245 1 0 _aPathologic Myopia
_cedited by Richard F. Spaide, Kyoko Ohno-Matsui, Lawrence A. Yannuzzi.
260 _aNew York
_bSpringer International Publishing
_c2014
300 _a1 recurso en línea (XVII, 376 p.)
_b233 ilustraciones, 170 ilustraciones en color
336 _aTexto (visual)
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
505 0 _a1. Myopia: A Historical Perspective -- 2. Genes involved in the development of myopia -- 3. Epidemiology of Myopia -- 4. Animal Models of Experimental Myopia: Limitations and Synergies With Studies on Human Myopia -- 5. The Sclera and its Role in Regulation of the Refractive State -- 6. Public Health Impact of Pathologic Myopia -- 7. Update on the Pathology of Pathologic Myopia -- 8.Â{u4A25} Sclera and Induced Abnormalities in Myopia -- 9. The Choroid -- 10.Â{u4A25} Optic Nerve in High Myopia -- 11.Â{u6A74}reous Changes -- 12.Â{u3D21}phyloma, Part 1 -- 13. Staphyloma, Part 2 -- 14. Myopic Chorioretinal Atrophy -- 15.Â{u3A2F}oroidal Neovascularization -- 16.Â{u0379}opic Macular Retinoschisis -- 17. Peripheral Retinal Abnormalities -- 18.Â{u2974}inal Detachment -- 19.Â{u7B21}aucoma in Myopia -- 20.Â{uDE6F}opic Optic Neuropathy -- 21. Special Considerations for Cataract Surgery in the Face of Pathologic Myopia -- 22. Ocular Motility Abnormalities -- 23. Myopia: Ocular and Systemic Disease -- 24. Prevention of Myopia -- 25. Sclera-targeted Therapies for Pathologic Myopia.
520 _aPathological Myopia is a major cause of severe vision loss worldwide. The mechanisms for vision loss include cataract, glaucoma, retinal detachment, and above all, degeneration of the macula within the posterior staphyloma. Pathological Myopia is one of the only current books to specifically address this disease and discusses recent developments in imaging technologies and various approaches to treatments, such as laser photocoagulation, photodynamic therapy, pharmaco-therapeutic injections in the vitreous, and surgery.Â{u2820} Complete with high-quality color images, this book is written and edited by leaders in the field and is geared towards ophthalmologists, including residents and fellows in training, glaucoma and cataract specialists, and vitreoretinal macula experts.
650 7 _2embne
_9190667
_aRetina
_xEnfermedades
700 1 _aSpaide, Richard F
_eeditor literario
_988147
_0Local
700 1 _aOhno-Matsui, Kyoko
_eeditor literario
_988148
_0Local
700 1 _aYannuzzi, Lawrence A
_eeditor literario
_988149
_0Local
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-1-4614-8338-0
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907 _a.b12879319
_b10-10-17
_c11-11-15
942 _2lcc
_cLE
945 _aRE661.D3 P384 2014 EB
_g1
_ieBOOK
_j0
_lmae
_o-
_pEUR0.00
_q-
_r-
_sb
_t15
_u0
_v0
_w0
_x0
_y.i11559135
_z06-04-17
988 _aEBSPRINGER
998 _am
_a_alco
_a_vill
_b11-11-15
_cm
_dz
_e-
_feng
_gxxu
_h0